MedTrace Logo

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

NCT01938651 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-08-03

No results posted yet for this study

Summary

This pilot clinical trial studies ultra-high field magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) techniques in diagnosing breast cancer. New diagnostic procedures may be a more sensitive way to detect breast cancer.

Conditions

Interventions

PROCEDURE

high field strength magnetic resonance imaging

Undergo 7T MRI

PROCEDURE

magnetic resonance spectroscopic imaging

Undergo 31P MRS

PROCEDURE

chemical exchange saturation transfer magnetic resonance imaging

Undergo CEST-MRI

PROCEDURE

diffusion-weighted magnetic resonance imaging

Undergo DW-MRI

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Undergo DCE-MRI

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Thomas Yankeelov · Vanderbilt-Ingram Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938651 on ClinicalTrials.gov